Skip to main content

Partnering Insights

Subscribe to get partnering research, trends & best practices delivered straight to your inbox.

By submitting this form, you agree to the storing and processing of your personal data by Inpart as detailed in the Privacy Statement.

Best practices

Biotech assets & discovery platforms R&D trends and breakthrough innovations
Biotech assets & discovery platforms R&D trends and breakthrough innovations
Connecting
Biotech assets & discovery platforms R&D trends and breakthrough innovations
Oncology R&D trends and breakthrough innovations
Oncology R&D trends and breakthrough innovations
Connecting
Oncology R&D trends and breakthrough innovations
Partnering 2030: FME Industries Report
Connecting
Partnering 2030: FME Industries Report
Partnering 2030: Biopharma Report
Connecting
Partnering 2030: Biopharma Report
Biopharma Dealmaking 2025
Biopharma Dealmaking 2025
Execution
Biopharma Dealmaking 2025
Antibody Therapy R&D trends and breakthrough innovations
Antibody Therapy R&D trends and breakthrough innovations
Connecting
Antibody Therapy R&D trends and breakthrough innovations
The hidden value of research facilities
The hidden value of research facilities
Connecting
The hidden value of research facilities
Nanotechnology R&D trends and breakthrough innovations
Nanotechnology R&D trends and breakthrough innovations
Connecting
Nanotechnology R&D trends and breakthrough innovations
Eye health R&D trends and breakthrough innovations
Eye health R&D trends and breakthrough innovations
Connecting
Eye health R&D trends and breakthrough innovations
Sustainable agriculture and food: R&D trends
Sustainable agriculture and food: R&D trends
Connecting
Sustainable agriculture and food: R&D trends
Sustainable agriculture and food: R&D trends and predictions 2024
Sustainable agriculture and food: R&D trends and predictions 2024
Connecting
Sustainable agriculture and food: R&D trends and predictions 2024
Connect with R&D teams working on agriculture and food sustainability - Merck and GFI
Connect with R&D teams working on agriculture and food sustainability - Merck and GFI
Connecting
Connect with R&D teams working on agriculture and food sustainability - Merck and GFI
Respiratory disease R&D trends and breakthrough innovations
Respiratory disease R&D trends and breakthrough innovations
Connecting
Respiratory disease R&D trends and breakthrough innovations
Accelerating Innovation with J&J
Accelerating Innovation with J&J
Execution
Accelerating Innovation with J&J
Partner with R&D teams working on agriculture and food sustainability - CP Foods
Partner with R&D teams working on agriculture and food sustainability - CP Foods
Connecting
Partner with R&D teams working on agriculture and food sustainability - CP Foods
Partner with R&D teams working on agriculture and food sustainability - Bel and Carrot Ventures
Partner with R&D teams working on agriculture and food sustainability - Bel and Carrot Ventures
Connecting
Partner with R&D teams working on agriculture and food sustainability - Bel and Carrot Ventures
Partner with R&D teams working on agriculture and food sustainability - Hochland and Incotec
Partner with R&D teams working on agriculture and food sustainability - Hochland and Incotec
Connecting
Partner with R&D teams working on agriculture and food sustainability - Hochland and Incotec
Partner with R&D teams working on agriculture and food sustainability - Merck and GFI
Partner with R&D teams working on agriculture and food sustainability - Merck and GFI
Connecting
Partner with R&D teams working on agriculture and food sustainability - Merck and GFI
Partner with R&D teams working on agriculture and food sustainability
Partner with R&D teams working on agriculture and food sustainability
Connecting
Partner with R&D teams working on agriculture and food sustainability
Data Driven Dealmaking with Inpart Deal and Evaluate
Data Driven Dealmaking with Inpart Deal and Evaluate
Execution
Data Driven Dealmaking with Inpart Deal and Evaluate
Trends, analysis and forecasts for biopharma dealmaking in 2024
Trends, analysis and forecasts for biopharma dealmaking in 2024
Execution
Trends, analysis and forecasts for biopharma dealmaking in 2024
Sustainable materials for a circular economy: R&D trends report for 2024
Sustainable materials for a circular economy: R&D trends report for 2024
Connecting
Sustainable materials for a circular economy: R&D trends report for 2024
Sustainable materials for a circular economy: R&D trends for 2024
Sustainable materials for a circular economy: R&D trends for 2024
Connecting
Sustainable materials for a circular economy: R&D trends for 2024
Partnering 2030: The Biotech Perspective 2023
Partnering 2030: The Biotech Perspective 2023
Connecting
Partnering 2030: The Biotech Perspective 2023
Biopharma Dealmaking 2024
Biopharma Dealmaking 2024
Execution
Biopharma Dealmaking 2024
Setting a Strategy for Partnering Success
Setting a Strategy for Partnering Success
Execution
Setting a Strategy for Partnering Success
Partner of Choice. By Choice.
Partner of Choice. By Choice.
Connecting
Partner of Choice. By Choice.
Five focus areas to level up your alliance management practice
Five focus areas to level up your alliance management practice
Execution
Five focus areas to level up your alliance management practice
Partnering 2030: The Biotech Perspective 2022
Partnering 2030: The Biotech Perspective 2022
Connecting
Partnering 2030: The Biotech Perspective 2022
New routes to source innovation from academia
New routes to source innovation from academia
Connecting
New routes to source innovation from academia
Due diligence best practices
Execution
Due diligence best practices
What reporting data are top pharma R&D and BD?
Execution
What reporting data are top pharma R&D and BD?
Everyone's a scout
Everyone's a scout
Connecting
Everyone's a scout
What’s next for the university-industry ecosystem after COVID-19?
What’s next for the university-industry ecosystem after COVID-19?
Connecting
What’s next for the university-industry ecosystem after COVID-19?
What do R&D teams want from universities?
What do R&D teams want from universities?
Connecting
What do R&D teams want from universities?
Behind the scenes of a billion dollar pharma deal
Behind the scenes of a billion dollar pharma deal
Connecting
Behind the scenes of a billion dollar pharma deal
Reducing Risk & Driving Successful Partnerships
Reducing Risk & Driving Successful Partnerships
Execution
Reducing Risk & Driving Successful Partnerships
The biotech journey: from inception to exit
The biotech journey: from inception to exit
Execution
The biotech journey: from inception to exit
Building a Business Development Powerhouse
Building a Business Development Powerhouse
Execution
Building a Business Development Powerhouse
How Best Practices Powered by Technology Drive Successful Relationships
How Best Practices Powered by Technology Drive Successful Relationships
Execution
How Best Practices Powered by Technology Drive Successful Relationships
Driving successful alliance management in life sciences
Execution
Driving successful alliance management in life sciences
Optimizing biopharma Business Development
Execution
Optimizing biopharma Business Development
Engage researchers with commercialisation and tech transfer
Engage researchers with commercialisation and tech transfer
Connecting
Engage researchers with commercialisation and tech transfer
Life Sciences Search & Evaluation Best Practices
Life Sciences Search & Evaluation Best Practices
Connecting
Life Sciences Search & Evaluation Best Practices
Alliance management best practices
Execution
Alliance management best practices

We help bring science to life.

Products
Connect
Deal
Event
Get started
Network
About
Global Challenges
Campaigns
Join the network
Platform
Holistic partnering
Connecting
Networking
Execution
Trust
Security & Compliance
Resources
Blog
Partnering insights
Labiotech.eu
Company
About us
Contact us
© 2025 Inpart Privacy policy Terms of use